Breaking News Instant updates and real-time market news.

RARE

Ultragenyx

$82.98

4.33 (5.51%)

09:55
08/29/18
08/29
09:55
08/29/18
09:55

Piper ups Ultragenyx target to $89 on 'surprise' UX007 filing acceptance

Piper Jaffray analyst Christopher Raymond raised his price target for Ultragenyx Pharmaceutical to $89 from $85 on news that FDA has accepted the company's proposal to submit for approval of UX007 in long-chain fatty acid oxidation disorders, based on existing data. The news pulls commercialization forward by upwards of one year plus, Raymond tells investors in a research note titled "Surprise, Surprise! FDA Appears Fine With Early Trihep FAOD Filing." He points out that management's overall tone on the potential for filing early was very cautious. The analyst thinks many investors will be surprised by today's development and that shares will react favorably. Raymond keeps an Overweight rating on Ultragenyx.

  • 12

    Sep

  • 12

    Sep

RARE Ultragenyx
$82.98

4.33 (5.51%)

08/03/18
PIPR
08/03/18
NO CHANGE
Target $85
PIPR
Overweight
Ultragenyx price target raised to $85 from $67 at Piper Jaffray
Piper Jaffray analyst Christopher Raymond raised his price target for Ultragenyx to $85 and keeps an Overweight rating on the shares following the company's Q2 update. It looks like the launch of Crysvita is going well, Raymond tells investors in a research note. He continues to like the setup for the stock and would be buyers at current levels.
08/03/18
LEHM
08/03/18
NO CHANGE
Target $92
LEHM
Overweight
Ultragenyx price target raised to $92 from $74 at Barclays
Barclays analyst Gena Wang raised her price target for Ultragenyx to $92 saying the company for Q2 reported encouraging initial launch metrics for Crysvita in the U.S. The analyst sees multiple catalysts in the second half of 2018, including continued Crysvita commercial launch, clinical readouts from gene therapy programs DTX301 and DTX401, and regulatory feedback for UX007 in LC-FAOD. She reiterates an Overweight rating on Ultragenyx.
08/06/18
WEDB
08/06/18
NO CHANGE
Target $80
WEDB
Outperform
Ultragenyx price target raised to $80 from $71 at Wedbush
Wedbush analyst David Nierengarten raised his price target for Ultragenyx to $80 from $71 after the company reported a solid start to Crysvita sales in the U.S., with rate of adult adoption and reimbursement particularly encouraging for potential growth opportunity. The analyst reiterates an Outperform rating on the shares.
08/20/18
RHCO
08/20/18
NO CHANGE
Target $83
RHCO
Buy
Ultragenyx price target raised to $83 from $69 at SunTrust
SunTrust analyst Edward Nash raised his price target on Ultragenyx to $83 and kept his Buy rating, saying the second half of 2018 should be "catalyst-rich" for the company. The analyst notes that he expects an E.U. approval for Mepsevii following a positive CHMP opinion along with two gene therapy programs, stating that these could be "significant value drivers" for the Ultragenyx stock.

TODAY'S FREE FLY STORIES

WAT

Waters

$189.76

0.085 (0.04%)

06:58
12/12/18
12/12
06:58
12/12/18
06:58
Downgrade
Waters rating change  »

Waters downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOS

Mosaic

$33.00

-0.17 (-0.51%)

06:55
12/12/18
12/12
06:55
12/12/18
06:55
Downgrade
Mosaic rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$142.07

0.2 (0.14%)

06:53
12/12/18
12/12
06:53
12/12/18
06:53
Periodicals
Facebook employees say Sandberg should retain her COO role, BI reports »

Over 70% of 595 Facebook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRAC

Keane Group

$8.88

0.54 (6.47%)

06:52
12/12/18
12/12
06:52
12/12/18
06:52
Earnings
Keane Group narrows Q4 revenue view to $490M from $470M-$500M »

Consensus for Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXK

Endeavour Silver

$1.89

-0.02 (-1.05%)

06:52
12/12/18
12/12
06:52
12/12/18
06:52
Hot Stocks
Endeavour Silver reports 'positive' drilling results for Parral Project »

Endeavour Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMHC

Building Materials Holding

$0.00

(0.00%)

, OC

Owens Corning

$45.99

-1.57 (-3.30%)

06:51
12/12/18
12/12
06:51
12/12/18
06:51
Downgrade
Building Materials Holding, Owens Corning rating change  »

Barclays downgrades BMC…

BMHC

Building Materials Holding

$0.00

(0.00%)

OC

Owens Corning

$45.99

-1.57 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNLF

Samsung

$0.00

(0.00%)

06:50
12/12/18
12/12
06:50
12/12/18
06:50
Periodicals
Samsung to shutdown one of its mobile phone plants in China, Reuters reports »

Samsung will end…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$20.95

0.28 (1.35%)

06:50
12/12/18
12/12
06:50
12/12/18
06:50
Hot Stocks
Mallinckrodt subsidiary receives CRL from FDA for Roxicodon tablets NDA »

SpecGx, a subsidiary of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

06:45
12/12/18
12/12
06:45
12/12/18
06:45
General news
Breaking General news story  »

Week of 12/7 MBA Mortgage…

FLR

Fluor

$33.82

-1.89 (-5.29%)

06:44
12/12/18
12/12
06:44
12/12/18
06:44
Downgrade
Fluor rating change  »

Fluor downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFX

Newfield Exploration

$15.59

-0.03 (-0.19%)

06:44
12/12/18
12/12
06:44
12/12/18
06:44
Downgrade
Newfield Exploration rating change  »

Newfield Exploration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PXD

Pioneer Natural

$138.63

-2.01 (-1.43%)

06:44
12/12/18
12/12
06:44
12/12/18
06:44
Downgrade
Pioneer Natural rating change  »

Pioneer Natural…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

IBM

IBM

$120.88

-0.25 (-0.21%)

, ORCL

Oracle

$46.47

-0.21 (-0.45%)

06:43
12/12/18
12/12
06:43
12/12/18
06:43
Periodicals
GAO rejects IBM's challenge to Pentagon's $10B cloud contract, Bloomberg reports »

The U.S. Government…

IBM

IBM

$120.88

-0.25 (-0.21%)

ORCL

Oracle

$46.47

-0.21 (-0.45%)

AMZN

Amazon.com

$1,643.50

3.13 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

  • 20

    Dec

  • 03

    Mar

O

Realty Income

$66.30

0.58 (0.88%)

06:40
12/12/18
12/12
06:40
12/12/18
06:40
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRT

Federal Realty

$133.31

0.43 (0.32%)

06:40
12/12/18
12/12
06:40
12/12/18
06:40
Downgrade
Federal Realty rating change  »

Federal Realty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

MAR

Marriott

$110.04

-0.78 (-0.70%)

06:39
12/12/18
12/12
06:39
12/12/18
06:39
Downgrade
Marriott rating change  »

Marriott downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHIY

Hitachi

$0.00

(0.00%)

, ABB

ABB

$18.87

-0.08 (-0.42%)

06:39
12/12/18
12/12
06:39
12/12/18
06:39
Periodicals
Hitachi in final stages of preparing bid for ABB unit, Nikkei reports »

Hitachi (HTHIY) is in the…

HTHIY

Hitachi

$0.00

(0.00%)

ABB

ABB

$18.87

-0.08 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

H

Hyatt

$67.43

-1.41 (-2.05%)

06:39
12/12/18
12/12
06:39
12/12/18
06:39
Downgrade
Hyatt rating change  »

Hyatt downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HST

Host Hotels

$17.97

-0.13 (-0.72%)

06:39
12/12/18
12/12
06:39
12/12/18
06:39
Downgrade
Host Hotels rating change  »

Host Hotels downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USDP

USD Partners

$10.27

-0.23 (-2.19%)

06:38
12/12/18
12/12
06:38
12/12/18
06:38
Hot Stocks
USD Partners enters into new Casper Terminal pipeline construction contract »

USD Partners has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$7.31

-0.12 (-1.62%)

06:38
12/12/18
12/12
06:38
12/12/18
06:38
Conference/Events
Noodles & Company management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RNSDF

Renault

$0.00

(0.00%)

, NSANY

Nissan

$0.00

(0.00%)

06:36
12/12/18
12/12
06:36
12/12/18
06:36
Periodicals
Renault tells Nissan to stop contacting board members, Reuters reports »

Renault (RNSDF) has told…

RNSDF

Renault

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

UIS

Unisys

$12.72

-0.32 (-2.45%)

06:36
12/12/18
12/12
06:36
12/12/18
06:36
Recommendations
Unisys analyst commentary  »

Unisys price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACIU

AC Immune

$11.58

0.63 (5.75%)

, LLY

Eli Lilly

$114.49

0.38 (0.33%)

06:32
12/12/18
12/12
06:32
12/12/18
06:32
Hot Stocks
AC Immune, Eli Lilly announce license and collaboration agreement »

AC Immune (ACIU) and Eli…

ACIU

AC Immune

$11.58

0.63 (5.75%)

LLY

Eli Lilly

$114.49

0.38 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

OMI

Owens & Minor

$7.11

-0.19 (-2.60%)

06:32
12/12/18
12/12
06:32
12/12/18
06:32
Hot Stocks
Owens & Minor names Robert Snead as EVP & CFO »

Owens & Minor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.